DOCSLIB.ORG

Sleep Quality in Parkinson Disease: an Examination of Clinical Variables Karina Stavitsky, MA and Alice Cronin-Golomb, Phd

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Sleep Quality in Parkinson Disease: an Examination of Clinical Variables Karina Stavitsky, MA and Alice Cronin-Golomb, Phd ORIGINAL STUDY Sleep Quality in Parkinson Disease: An Examination of Clinical Variables Karina Stavitsky, MA and Alice Cronin-Golomb, PhD disturbances may also be secondary to motor discomfort3 Abstract: The etiology of sleep problems in Parkinson disease or to nonmotor features of the disease.4 Dopaminergic (PD) is not well understood, as they may arise from the medication may increase sleep fragmentation and reduce pathology of the disease or from other disease-related factors sleep efficiency,5 or may cause daytime sleepiness.3,6 such as motor dysfunction, dopaminergic medication, and mood Anxiety and depression, common in PD, can also cause disturbances. The aim of this study was to investigate factors problems with sleep onset and maintenance and daytime associated with sleep, including disease-related variables such as alertness.7,8 motor symptom severity, dose of medication, and mood and PD is heterogeneous in its presentation. Studies disease subtypes. Thirty-five nondemented patients with PD were have focused on disease subtypes including PD into left included. Sleep was measured using 24-hour wrist actigraphy (LPD) and right (RPD) side of motor symptom onset, over a 7-day period, during which time participants kept a sleep type of initial motor symptom, and sex. Differences in diary. Subjective sleep and arousal questionnaires included the cognitive performance, disease progression, and nonmo- PD Sleep Scale and Epworth Sleepiness Scale. Motor symptom tor features have been reported in subtypes of the disease. severity and dopaminergic medication were significantly related In regard to side of onset, LPD and RPD show distinct to measures of sleep quality. Sex differences in sleep quality were profiles of cognitive functioning,9,10 sleep disturbances,11 found, with men having worse sleep quality and more excessive and visual hallucinations.11,12 Findings of sleep differ- daytime sleepiness than women. We also found that actigraphy ences in LPD and RPD, however, have been limited to may serve as a useful tool for identifying individuals with use of sleep questionnaires. In regard to type of initial possible rapid eye movement behavior disorder, a sleep disorder motor symptom, individuals who present with tremor do- that has important implications in early detection of PD. minant (TD) versus nontremor dominant (NTD) symp- Key Words: Parkinson, sleep, actigraphy, sex toms express distinct clinical and cognitive profiles. Patients who present with primarily gait and balance (Cogn Behav Neurol 2011;24:43–49) disturbance tend to have more rapid progression of disease, including more severe cognitive deficits and a faster onset of dementia than patients with TD.13 No studies have leep problems in Parkinson disease (PD) are among examined sleep quality with respect to TD and NTD. Sthe most prominent nonmotor symptoms of the Sex differences have been found in both motor and disease, impacting the quality of life of patients and nonmotor aspects of PD.14 In the general population, caregivers.1 Patients with PD experience a variety of sleep- women report more frequent insomnia and restless legs related problems, including rapid eye movement (REM) syndrome, whereas REM behavior sleep disorder, char- Behavior Disorder (RBD), sleep fragmentation and acterized by loss of normal muscle atonia and acting-out reduced sleep efficiency, and excessive daytime sleepiness.1 of dreams, is more common in men.15 The examination of Some aspects of sleep disruption arise from the sleep quality with respect to sex has not been investigated underlying pathology of the disease.2 The pathogenesis of in patients with PD. PD, which begins in the brainstem and results in neuronal The aim of this study was to examine the association loss in the cholinergic, dopaminergic, and serotonergic of sleep and varying clinical presentations and symp- systems, is likely to affect the reticular formation that toms in patients with PD, using an objective measure is implicated in sleep and wake regulation.2 Sleep [actigraphy (ACT)] and subjective assessments (sleep questionnaires). This study focuses on the correlates of sleep disturbance in those with PD rather than the question Received for publication March 25, 2010; accepted March 14, 2011. of whether such disturbance exists, as this has already been From the Department of Psychology, Boston University, Boston, MA. demonstrated in numerous previous studies.1 Supported by a Ruth L. Kirschstein National Research Service Award (1F31 NS061555-01) and a Clara Mayo Foundation fellowship from the Department of Psychology, Boston University, to KS, and by NINDS grant R01 NS050446-01A2 to A.C-G. METHODS Reprints: Alice Cronin-Golomb, PhD, Department of Psychology, Boston University, 648 Beacon Street, 2nd floor, Boston, MA Participants 02215 (e-mail: [email protected]). Thirty-five patients with PD (22 men, 13 women) Copyright r 2011 by Lippincott Williams & Wilkins were recruited from the outpatient Movement Disorders Cogn Behav Neurol Volume 24, Number 2, June 2011 www.cogbehavneurol.com | 43 Stavitsky and Cronin-Golomb Cogn Behav Neurol Volume 24, Number 2, June 2011 Clinic at the Boston Medical Center (Table 1). The study sleep software version 5.3 (Mini Mitter). Results were was approved by the Boston University Institutional averaged across the 7 days of monitoring. The measures Review Board and all participants provided informed were sleep latency (first 10-min period with <2 epochs of consent. On the modified Mini-Mental State Examination activity), sleep time [sum of time (in minutes) of epochs (mMMSE),16 a cut-off score of 25 was used, as this form not exceeding the sensitivity threshold], sleep efficiency of the MMSE is particularly sensitive to specific cognitive (sleep time divided by the time in bed multiplied by 100), deficits found in PD without dementia (scores converted wake after sleep onset (total time awake after the first from the 57-point scale). Individuals with a history of sleep onset period), and movement and fragmentation substance abuse, head injury, or neurologic disorders be- index (number of 1-min periods of immobility relative to sides PD were excluded. None of the patients met criteria the total number of immobility phases). for dementia with Lewy bodies as per McKeith et al.17 Medication information was obtained for all parti- Subjective Measures cipants. Levodopa equivalent dosages (LED) were calcu- Sleep complaints were assessed using the Parkinson lated based on previous reports with LED: (regular Disease Sleep Scale (PDSS),20 which has been used to levodopa dose  1)+(levodopa controlled-release dose identify disturbances such as sleep maintenance, insom-  0.75)+(pramipexole dose  67.0)+(ropinirole dose nia, and excessive daytime sleepiness. The scale consists of  16.67)+(rotigotine  16.67)+(pergolide dose and 15 common symptoms. A score of 10 indicates worse cabergoline dose  67.0)+(bromocriptine dose  10)+ symptoms and 0 indicates no symptoms. We examined [(regular levodopa dose+levodopa controlled-release the 15 items as 9 factors comprising composite scores of dose  0.75)  0.25] (if taking tolcapone or entaca- the individual items, as described elsewhere.20 The factors pone)].18 were overall quality of sleep, sleep onset and maintena- Motor symptom severity was quantified using the nce, insomnia, nocturnal restlessness, nocturnal halluci- Unified Parkinson Disease Rating Scale (UPDRS) and nations, distressing/vivid dreams, nocturia, nocturnal Hoehn and Yahr stage. Information on the side and type motor symptoms (sensory complaints, early morning of motor symptom at onset was obtained through patient dystonia, and cramps during the night), sleep refresh- report, confirmed when possible by neurologist review. ment, and daytime dozing. We also used the PD Sleep Mood was assessed using the Beck Depression Inventory Questionnaire from our laboratory, which captures some (BDI-2) and Beck Anxiety Inventory (BAI). All patients symptoms not assessed by the PDSS, including questions received the PD Quality of Life questionnaire-39).19 assessing for RBD. Owing to the relationship between sleep disorders Sleep Measures and subjective daytime sleepiness, we administered the 21 Objective Measure Epworth Sleepiness Scale (ESS). The score range is 0 to To measure activity during the sleep/wake cycle, the 24, with a score of 10 or more indicating excessive day- time sleepiness. The questionnaire is commonly used in participants wore wrist actigraphs (Actiwatch AW-64; 22,23 Mini Mitter, Sunriver, OR) continuously over a 1-week PD to assess the likelihood of dozing off in a variety period on each wrist. Data from the nondominant wrist of daily situations. only was used for this study, as per convention. The Statistical Analyses actigraphs were set to a medium sensitivity with 40 counts Patients were recruited without regard to sex or assessed as “wake” and an epoch length of 30 seconds. motor symptom subtype. Independent sample t tests were The Actiwatch data were downloaded to the Actiware used to compare demographic and clinical characte- ristics of the sex and motor symptom subgroups. Pearson TABLE 1. Demographic and Clinical Characteristics of PD correlations reflected associations between sleep and Sample clinical variables such as mood and disease severity (ie, (n = 35) UPDRS total, disease stage and duration, and LED). Alpha of 0.01 was used for all correlations and analyses Age (y) 66.2 (7.9) Education (y) 16.8 (2.4) by subgroups. As there were significant correlations Men:women 22:13 among all 5 ACT variables, Bonferroni adjustment was BDI total 8.31 (4.7) used to set a to 0.01 (0.05/5). Of the 9 PDSS variables, BAI total 8.26 (4.9) only some of them were correlated (number de- UPDRS total 25.1 (9.4) Disease stage* 2 (2) pending on variable), and accordingly an a of 0.01 was Disease duration (y) 8.84 (5.1) used here as well. LED 604.3 (283.5) Dopamine agonist (%) 77.1 Sleep medication (%) 14.7 RESULTS Means (SD) are reported unless otherwise indicated.
Load more

Recommended publications
  • 533 BCBSA Reference Number: 2.01.73 NCD/LCD: N/A
    Medical Policy Actigraphy Table of Contents • Policy: Commercial • Coding Information • Information Pertaining to All Policies • Policy: Medicare • Description • References • Authorization Information • Policy History Policy Number: 533 BCBSA Reference Number: 2.01.73 NCD/LCD: N/A Related Policies Surgical Treatment of Snoring and Obstructive Sleep Apnea Syndrome, #130 Policy Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity Medicare HMO BlueSM and Medicare PPO BlueSM Members Actigraphy as a technique to record and analyze body movement, including but not limited to its use to evaluate sleep disorders, is INVESTIGATIONAL. Prior Authorization Information Inpatient • For services described in this policy, precertification/preauthorization IS REQUIRED for all products if the procedure is performed inpatient. Outpatient • For services described in this policy, see below for products where prior authorization might be required if the procedure is performed outpatient. Outpatient Commercial Managed Care (HMO and POS) This is not a covered service. Commercial PPO and Indemnity This is not a covered service. Medicare HMO BlueSM This is not a covered service. Medicare PPO BlueSM This is not a covered service. CPT Codes / HCPCS Codes / ICD Codes Inclusion or exclusion of a code does not constitute or imply member coverage or provider reimbursement. Please refer to the member’s contract benefits in effect at the time of service to determine coverage or non-coverage as it applies to an individual member. 1 Providers should report all services using the most up-to-date industry-standard procedure, revenue, and diagnosis codes, including modifiers where applicable. CPT Codes CPT codes: Code Description 95803 Actigraphy testing, recording, analysis, interpretation and report (minimum of 72 hours to 14 consecutive days of recording) ICD Diagnosis Codes Investigational for all diagnoses.
    [Show full text]
  • ACTIGRAPHY Wactisleep-BT Monitor Micro Motionlogger Watch Motionlogger Watch Motionwatch 8 Actiwatch Spectrum Somnowatch
    Company ActiGraph Ambulatory Monitoring Inc CamNtech Philips Respironics SOMNOmedics America Inc Product Name ACTIGRAPHY wActiSleep-BT Monitor Micro Motionlogger Watch Motionlogger Watch MotionWatch 8 Actiwatch Spectrum SOMNOwatch www.ambulatory-monitoring. www.ambulatory-monitoring. www.somnomedics- Website www.actigraphcorp.com www.camntech.com www.philips.com/actigraphy com com diagnostics.com 1-year standard warranty; Cost/Warranty $299/1 year 1 year 1 year $750/2 years 2 years extended warranty available 3-axis solid state Miniaturized poly-silicone-surface Accelerometer accelerometer with digital Solid state triaxial Solid state triaxial MEMS – 3 axis Solid-state “piezoelectric” micromachined Technology filtering sensor (MEMS) 3.81 cm x 2.54 cm x 1.016 Product Dimensions 4.6 cm x 3.3 cm x 1.9 cm 3.6 cm x 3.6 cm x 1.2 cm 5.5 cm x 4.5 cm x 1.8 cm H 4.8 cm x 3.7 cm x 1.4 cm 4.5 cm x 4.5 cm x 1.6 cm cm Weight, Including 22 grams 30 grams 65 grams 16.8 grams 30 grams 30 grams Batteries and Wrist Band Rechargeable lithium Li-Ion-Accu, inbuilt, Batteries 1 DL2430 disposable coin cell 1 DL2450 disposable coin cell Common watch R2032 Lithium coin cell CR 2430 polymer rechargeable 1-year battery life (with continuous Battery Life 31 days 30+ days 30+ days 1 year 26+ days use at 1-minute epoch) Type of Memory Storage 2 GB nonvolatile 2 MB nonvolatile 2 MB nonvolatile 4 MB nonvolatile 2 MB nonvolatile 8 MB internal storage card Recording Time at 1- 36 days—Activity plus 120 days 30+ days 30+ days 182 days 45 days Minute Sample Interval 4 channels
    [Show full text]
  • And Irregular Sleep-Wake-Rhythm Disorder (ISWRD): How Many Days Are Needed for Reliable Measures?
    Activity Monitoring in patients with Alzheimer’s Disease (AD) and Irregular Sleep-Wake-Rhythm Disorder (ISWRD): How Many Days are needed for reliable measures? Manuel Kemethofer1, Georg Gruber1, Georg Dorffner1,2, Silvia Parapatics1, Erna Loretz1, Marco Hirner1, Mohammad Bsharat3, Gleb Filppov3, Naoki Kubota4, Margaret Moline3 Affiliations: 1: The Siesta Group; 2: Medical University of Vienna, Section for Artificial Intelligence and Decision Support, Vienna, Austria; 3: Eisai, Inc., Woodcliff Lake, NJ, USA; 4: Eisai Co., Ltd. Tokyo, Japan Methodological Question How many days of actigraphy data are needed for reliable measures of sleep-wake patterns in patients with AD and ISWRD? Introduction When sleep is not consolidated at night but rather distributed in irregular sleep bouts across the 24- hour period, this condition is referred to as Irregular Sleep-Wake Rhythm Disorder (ISWRD) and often appears early in the course of Alzheimer’s Disease (AD). To obtain reliable information about a patient’s sleep-wake rhythm, multiple 24-hour periods must be investigated. With actigraphy this is possible. For children and adolescents, it is recommended1 to record at least one week of actigraphy data to provide an adequate information. However, it is still unclear how many days of actigraphy data are needed for determining reliable measures of sleep-wake patterns in patients with AD and ISWRD. Methods A retrospective analysis of data from 121 subjects (aged 60 – 90 years) with a diagnosis of mild to moderate Alzheimer’s Disease, a Mini–Mental State Examination score between 10-26 and complaints of difficulties with both staying asleep during night and staying awake during day occurring at least 3 times per week for at least 3 months was performed.
    [Show full text]
  • Actigraphy As a Diagnostic Aid for REM Sleep Behavior Disorder In
    Louter et al. BMC Neurology 2014, 14:76 http://www.biomedcentral.com/1471-2377/14/76 RESEARCH ARTICLE Open Access Actigraphy as a diagnostic aid for REM sleep behavior disorder in Parkinson’s disease Maartje Louter1,2, Johan BAM Arends3,4, Bastiaan R Bloem1 and Sebastiaan Overeem1,2* Abstract Background: Rapid eye movement (REM) sleep behavior disorder (RBD) is a common parasomnia in Parkinson’s disease (PD) patients. The current International Classification of Sleep Disorders (ICSD-II) requires a clinical interview combined with video polysomnography (video-PSG) to diagnose. The latter is time consuming and expensive and not always feasible in clinical practice. Here we studied the use of actigraphy as a diagnostic tool for RBD in PD patients. Methods: We studied 45 consecutive PD patients (66.7% men) with and without complaints of RBD. All patients underwent one night of video-PSG and eight consecutive nights of actigraphy. Based on previous studies, the main outcome measure was the total number of bouts classified as “wake”, compared between patients with (PD + RBD) and without RBD (PD- RBD). Results: 23 (51.1%) patients had RBD according to the ICSD-II criteria. The total number of wake bouts was significantly higher in RBD patients (PD + RBD 73.2 ± 40.2 vs. PD-RBD 48.4 ± 23.3, p = .016). A cut off of 95 wake bouts per night resulted in a specificity of 95.5%, a sensitivity of 20.1% and a positive predictive value of 85.7%. Seven patients were suspected of RBD based on the interview alone, but not confirmed on PSG; six of whom scored below 95 wake bouts per night on actigraphy.
    [Show full text]
  • Non-24-Hour Sleep-Wake Disorder Revisited – a Case Study
    CASE REPORT published: 29 February 2016 doi: 10.3389/fneur.2016.00017 Non-24-Hour Sleep-Wake Disorder Revisited – a Case study Corrado Garbazza1,2† , Vivien Bromundt3† , Anne Eckert2,4 , Daniel P. Brunner5 , Fides Meier2,4 , Sandra Hackethal6 and Christian Cajochen1,2* 1 Centre for Chronobiology, Psychiatric Hospital of the University of Basel, Basel, Switzerland, 2 Transfaculty Research Platform Molecular and Cognitive Neurosciences, University of Basel, Basel, Switzerland, 3 Sleep-Wake-Epilepsy-Centre, Department of Neurology, Inselspital, Bern University Hospital, Bern, Switzerland, 4 Neurobiology Laboratory for Brain Aging and Mental Health, Psychiatric Hospital of the University of Basel, Basel, Switzerland, 5 Center for Sleep Medicine, Hirslanden Clinic Zurich, Zurich, Switzerland, 6 Charité – Universitaetsmedizin Berlin, Berlin, Germany The human sleep-wake cycle is governed by two major factors: a homeostatic hourglass process (process S), which rises linearly during the day, and a circadian process C, which determines the timing of sleep in a ~24-h rhythm in accordance to the external Edited by: Ahmed S. BaHammam, light–dark (LD) cycle. While both individual processes are fairly well characterized, the King Saud University, Saudi Arabia exact nature of their interaction remains unclear. The circadian rhythm is generated by Reviewed by: the suprachiasmatic nucleus (“master clock”) of the anterior hypothalamus, through Axel Steiger, cell-autonomous feedback loops of DNA transcription and translation. While the phase Max Planck Institute of Psychiatry, Germany length (tau) of the cycle is relatively stable and genetically determined, the phase of Timo Partonen, the clock is reset by external stimuli (“zeitgebers”), the most important being the LD National Institute for Health and Welfare, Finland cycle.
    [Show full text]
  • The Feasibility of Sleep Assessment by Actigraph in Patients with Tetraplegia
    Spinal Cord (2007) 45, 765–770 & 2007 International Spinal Cord Society All rights reserved 1362-4393/07 $30.00 www.nature.com/sc Original Article The feasibility of sleep assessment by actigraph in patients with tetraplegia E Spivak1, A Oksenberg2 and A Catz*,1,3 1Department of Spinal Rehabilitation, Loewenstein Rehabilitation Hospital, Raanana, Israel; 2Sleep Disorders Unit at Loewenstein Rehabilitation Hospital, Raanana, Israel; 3Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel Background: Sleep disturbances are frequent in patients with high spinal cord lesions, and are difficult to diagnose by means of polysomnography (PSG). Design: Retrospective cohort study. Objective: Examine the feasibility of sleep assessment by actigraph in patients with tetraplegia. Setting: A rehabilitation center in Israel. Subjects: Twenty-one patients with tetraplegia and 20 healthy persons. Interventions: Sleep assessment by actigraphs attached tothe head and the wrist. Main outcome measures: The actigraphic movement index (MI), total sleep time (TST), sleep efficiency (SE), wake after sleep onset (WASO), sleep latency (SL), and number of awakenings (NOA). Results: In the control group actigraphy showed that during sleep the hand moves more than the head but that the movements were highly correlated. In patients with tetraplegia below C5–C7 the hand also moved more than the head, but in patients with tetraplegia below C4, the head moved more (Po0.05). Nosignificant differences were found between patients with C 5–C7 tetraplegia and healthy controls in the sleep indices obtained by hand movements, or between patients with C4 tetraplegia and healthy controls in the indices obtained by head movements. Control subjects and patients showed similar subjective assessment of sleep quality.
    [Show full text]
  • Trauma Associated Sleep Disorder: a Parasomnia Induced by Trauma
    Sleep Medicine Reviews 37 (2018) 94e104 Contents lists available at ScienceDirect Sleep Medicine Reviews journal homepage: www.elsevier.com/locate/smrv THEORETICAL REVIEW Trauma associated sleep disorder: A parasomnia induced by trauma * Vincent Mysliwiec a, , Matthew S. Brock a, Jennifer L. Creamer b, Brian M. O'Reilly b, Anne Germain c, d, Bernard J. Roth b a San Antonio Military Medical Center, Department of Sleep Medicine, 2200 Bergquist Drive, Suite 1, JBSA Lackland, TX 78236, USA b Madigan Army Medical Center, Department of Pulmonary, Critical Care, and Sleep Medicine, Tacoma, WA, USA c University of Pittsburgh School of Medicine, Department of Psychiatry, Pittsburgh, PA, USA d University of Pittsburgh School of Medicine, Department of Psychology, Pittsburgh, PA, USA article info summary Article history: Nightmares and disruptive nocturnal behaviors that develop after traumatic experiences have long been Received 15 May 2016 recognized as having different clinical characteristics that overlap with other established parasomnia Received in revised form diagnoses. The inciting experience is typically in the setting of extreme traumatic stress coupled with 12 January 2017 periods of sleep disruption and/or deprivation. The limited number of laboratory documented cases and Accepted 20 January 2017 symptomatic overlap with rapid eye movement sleep behavior disorder (RBD) and posttraumatic stress Available online 30 January 2017 disorder (PTSD) have contributed to difficulties in identifying what is a unique parasomnia. Trauma associated
    [Show full text]
  • 2.01.73 Actigraphy
    MEDICAL POLICY – 2.01.73 Actigraphy BCBSA Ref. Policy: 2.01.73 Effective Date: Sept. 1, 2021 RELATED MEDICAL POLICIES: Last Revised: Aug. 3, 2021 None Replaces: N/A Select a hyperlink below to be directed to that section. POLICY CRITERIA | CODING | RELATED INFORMATION EVIDENCE REVIEW | REFERENCES | HISTORY ∞ Clicking this icon returns you to the hyperlinks menu above. Introduction Actigraphy is the recording of how a body moves. Actigraphy uses a small device that is usually placed on the wrist or ankle. In some cases the device is placed on a leg to assess restless legs syndrome. It also has been used to try to look at a person’s sleep-wake cycles. High quality medical studies do not show that actigraphy works as well as or better than the usual ways of determining sleep-wake cycles. For this reason, actigraphy is considered investigational (unproven). Note: The Introduction section is for your general knowledge and is not to be taken as policy coverage criteria. The rest of the policy uses specific words and concepts familiar to medical professionals. It is intended for providers. A provider can be a person, such as a doctor, nurse, psychologist, or dentist. A provider also can be a place where medical care is given, like a hospital, clinic, or lab. This policy informs them about when a service may be covered. Policy Coverage Criteria Service Investigational Actigraphy Actigraphy is considered investigational when used as the sole technique to record and analyze body movement, including but not limited to its use to evaluate sleep disorders. Note: This does not include the use of actigraphy as a component of portable sleep monitoring.
    [Show full text]
  • Actigraphy Original Effective Date: 9/16/20
    Subject: Actigraphy Original Effective Date: 9/16/20 Policy Number: MCP-374 Revision Date(s): Review Date: 11/18/20 MCPC Approval Date: 9/16/20 DISCLAIMER This Molina Clinical Policy (MCP) is intended to facilitate the Utilization Management process. It expresses Molina's determination as to whether certain services or supplies are medically necessary, experimental, investigational, or cosmetic for purposes of determining appropriateness of payment. The conclusion that a particular service or supply is medically necessary does not constitute a representation or warranty that this service or supply is covered (i.e., will be paid for by Molina) for a particular member. The member's benefit plan determines coverage. Each benefit plan defines which services are covered, which are excluded, and which are subject to dollar caps or other limits. Members and their providers will need to consult the member's benefit plan to determine if there are any exclusion(s) or other benefit limitations applicable to this service or supply. If there is a discrepancy between this policy and a member's plan of benefits, the benefits plan will govern. In addition, coverage may be mandated by applicable legal requirements of a State, the Federal government or CMS for Medicare and Medicaid members. CMS's Coverage Database can be found on the CMS website. The coverage directive(s) and criteria from an existing National Coverage Determination (NCD) or Local Coverage Determination (LCD) will supersede the contents of this Molina Clinical Policy (MCP) document and
    [Show full text]
  • Circadian Rhythm Sleep Disorders
    alt y He hca ar re : im O r p P e f n o A l c a Wells and Overton, Primary Health Care 2014, 4:2 c n e r s u Primary Health Care: Open Access s o DOI: 10.4172/2167-1079.1000158 J ISSN: 2167-1079 Review Article Open Access Circadian Rhythm Sleep Disorders Mary Ellen Wells1* and Auburne Overton1 1University of North Carolina, USA *Corresponding author: Mary Ellen Wells, Assistant Professor, University of North Carolina at Chapel Hill, Allied Health Sciences, 301 A South Columbia StreetCB # 7120 Chapel Hill, NC27516, USA, Tel: 919-843-4673; Email: [email protected] Rec date: Mar 26, 2014, Acc date: May 20, 2014; Pub date: May 28, 2014 Copyright: © 2014 Wells ME, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Though the theories on the reasons why humans need to sleep vary, there is no disagreement that sleep is essential to our wellbeing and survival. External and internal physiological parameters dictate our own individual body “clocks,” or circadian rhythms. Typically, this clock runs very close to a 24-hour cycle of sleep and wakefulness. However, for some individuals, this clock can be slightly “off.” This article will discuss what creates internal circadian rhythms and the major types of circadian rhythm disorders, with an overview of diagnosis and treatment options. Keywords: Sleep medicine; Circadian rhythms; Sleep physiology; deprived of sleep will die within two to three weeks, a time frame Delayed phase sleep disorder; Advanced phase sleep disorder; Jet lag; similar to death due to starvation [5].” Non-entrained type; Free-running type; Irregular sleep-wake rhythm; A recent and widely accepted definition of sleep, according to the Shift work type American Academy of Sleep Medicine is: “Sleep is much more than a gentle ‘pause’ from your daily activities.
    [Show full text]
  • A Review of Sleep Diary Accuracy
    183 Original Article Assessing the sleeping habits of patients in a sleep disorder centre: a review of sleep diary accuracy Geoffrey Lawrence1, Rexford Muza2 1GKT School of Medical Education, King’s College London, London, UK; 2Sleep Disorders Centre, St Thomas’ Hospital, London, UK Contributions: (I) Conception and design: All authors; (II) Administrative support: R Muza; (III) Provision of study materials or patients: R Muza; (IV) Collection and assembly of data: G Lawrence; (V) Data analysis and interpretation: G Lawrence; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Rexford Muza. Sleep Disorders Centre, St Thomas’ Hospital, Guy’s Hospital Sleep Disorders Centre 3rd floor, Nuffield House Great Maze Pond, London SE1 9RT, UK. Email: [email protected]. Background: Excessive daytime sleepiness (EDS) is a complaint common to many aspects of medicine. There are primary and secondary causes for EDS, with secondary causes including a large number of common conditions. Primary causes, such as narcolepsy, are much rarer. When assessing for primary hypersomnia, restricted or fragmented sleep must be ruled out. This process involves assessment of sleeping habits using a sleep diary and/or actigraphy. Clinicians are suspicious of the accuracy with which patients use the former. This review aims to evaluate the accuracy of a sleep diary study against the ‘objective gold standard’ actigraphy report. Methods: Data from 35 patients at a Sleep Disorder Centre who underwent both a sleep diary and actigraphy study for suspected primary hypersomnia in 2016 was collected. Mean values of four variables were calculated: ‘time of lights out’, ‘time to fall asleep’, ‘time of waking’ and ‘sleep time’.
    [Show full text]
  • IH Summary: Characteristics & Diagnostic Criteria
    Idiopathic Hypersomnia (IH) Characteristics STANDARD CHARACTERISTICS: • Neurological disorder1, 3 • Chronic, usually lifelong after onset1, 2, 3, 4 • A central disorder of hypersomnolence (CDH), in the same category as narcolepsy1, 3 • Hallmark symptom: excessive daytime sleepiness (EDS), an uncontrollable need to sleep or daytime sleepiness that persists for at least 3 months even with adequate or prolonged nighttime sleep1, 2, 3, 4 POSSIBLE CHARACTERISTICS: • Debilitating, often significantly affecting social, school, and occupational functioning1, 2, 3, 4 • Onset usually in adolescence or early adulthood (but may be earlier or later)1, 2, 3, 4 • Seems to affect more females than males2, 3 • Fluctuating severity, with some time periods worse than others2, 4 • Daytime naps, which are generally long (over 1 hour) and usually not refreshing [frequent]1, 2, 3, 4 • Long sleep: sleeping 9 hours4 or more3 in 24 hours, which is usually un-refreshing [frequent]1, 2, 3, 4 • Sleep drunkenness (i.e., severe sleep inertia): extreme and prolonged difficulty fully awakening, associated with an uncontrollable desire to go back to sleep [frequent], which can be accompanied by automatic behavior (performing tasks without conscious self-control and with partial or total loss of memory), disorientation, confusion, irritability, and poor coordination1,2,3,4 • Motor hyperactivity ”e.g., “never stopping,” “speaking a lot”), serving as a countermeasure to boost alertness [frequent]2, 3, 4 • Cognitive dysfunction: deficits in memory, attention, and concentration (sometimes referred to informally as “brain fog”)2, 4 • Sleep hallucinations: hallucinations at sleep onset and/or offset occasional[ ]1, 3 • Sleep paralysis: a transitional state between wakefulness and sleep, in which one is aware but cannot move, speak, or react [occasional]1, 3 • Additional potential symptoms: headaches, automatic behaviors, problems with balance, and difficulties with temperature regulationoccasional [ ]2, 3, 4 • Unique anesthesia needs: see hypersomniafoundation.org/anesthesia-and-ih Sources: 1.
    [Show full text]